bioAffinity Technologies, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 40.1% | 40.1% | -435.3% |
| FY2022 | -73.8% | -73.8% | -66.9% |
| FY2023 | -163.5% | -163.5% | -96.5% |
| FY2024 | -347.4% | -347.4% | -138.8% |
| FY2025 | -204.9% | -204.9% | -136.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 40.1% | 40.1% | -435.3% |
| FY2022 | -73.8% | -73.8% | -66.9% |
| FY2023 | -163.5% | -163.5% | -96.5% |
| FY2024 | -347.4% | -347.4% | -138.8% |
| FY2025 | -204.9% | -204.9% | -136.0% |